Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Fitzmaurice, David A."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-18 z 18
    Tytuł:
    Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
    Autorzy:
    Haas S; Formerly Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
    Ten Cate H; Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
    Accetta G; Thrombosis Research Institute, London, United Kingdom.
    Angchaisuksiri P; Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Bassand JP; Thrombosis Research Institute, London, United Kingdom.; Department of Cardiology, EA 3920, University of Besançon, Besançon, France.
    Camm AJ; Division of Cardiovascular Sciences, St George's University of London, London, United Kingdom.
    Corbalan R; Department of Cardiology, Catholic University School of Medicine, Santiago, Chile.
    Darius H; Department of Cardiology, Vascular Medicine and Intensive Care Medicine, Vivantes Neukoelln Medical Centre, Berlin, Germany.
    Fitzmaurice DA; Department of Primary Care Clinical Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
    Goldhaber SZ; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.
    Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.
    Jacobson B; Department of Hematology and Molecular Medicine, Johannesburg Hospital, University of the Witwatersrand, Johannesburg, South Africa.
    Kayani G; Thrombosis Research Institute, London, United Kingdom.
    Mantovani LG; Center for Public Health Research (CESP), University of Milano-Bicocca, Milan, Italy.
    Misselwitz F; Bayer Pharma AG, Berlin, Germany.
    Pieper K; Duke Clinical Research Institute, Durham, NC, United States of America.
    Schellong SM; Internal Medicine, Dresden-Friedrichstadt Hospital, Dresden, Germany.
    Stepinska J; Intensive Cardiac Therapy Clinic, Institute of Cardiology, Warsaw, Poland.
    Turpie AG; Department of Medicine, McMaster University, Hamilton, Canada.
    van Eickels M; Bayer Pharma AG, Berlin, Germany.
    Kakkar AK; Thrombosis Research Institute, London, United Kingdom.; University College London, London, United Kingdom.
    Pokaż więcej
    Corporate Authors:
    GARFIELD-AF Investigators
    Źródło:
    PloS one [PLoS One] 2016 Oct 28; Vol. 11 (10), pp. e0164076. Date of Electronic Publication: 2016 Oct 28 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Anticoagulants/*administration & dosage
    Atrial Fibrillation/*drug therapy
    Vitamin K/*antagonists & inhibitors
    Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Antiplatyhelmintic Agents/administration & dosage ; Antiplatyhelmintic Agents/adverse effects ; Antiplatyhelmintic Agents/therapeutic use ; Atrial Fibrillation/mortality ; Female ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; International Normalized Ratio ; Male ; Middle Aged ; Prospective Studies ; Registries ; Risk Factors ; Stroke/prevention & control ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.
    Autorzy:
    Smith JD
    Baillie J; Marie Curie Palliative Care Research Centre, Cardiff University School of Medicine, Heath Park, Cardiff, Wales CF14 4YS, UK. .
    Baglin T
    Griffiths GO
    Casbard A
    Cohen D
    Fitzmaurice DA
    Hood K
    Rose P
    Cohen AT
    Johnson M
    Maraveyas A
    Bell J
    Toone H
    Nelson A
    Noble SI
    Pokaż więcej
    Źródło:
    Trials [Trials] 2014 Apr 12; Vol. 15, pp. 122. Date of Electronic Publication: 2014 Apr 12.
    Typ publikacji:
    Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Drug Costs*
    Research Design*
    Anticoagulants/*administration & dosage
    Anticoagulants/*economics
    Heparin, Low-Molecular-Weight/*administration & dosage
    Heparin, Low-Molecular-Weight/*economics
    Neoplasms/*complications
    Thrombosis/*drug therapy
    Anticoagulants/adverse effects ; Clinical Protocols ; Cost-Benefit Analysis ; Drug Administration Schedule ; Feasibility Studies ; Focus Groups ; Heparin, Low-Molecular-Weight/adverse effects ; Humans ; Interviews as Topic ; Neoplasms/blood ; Neoplasms/economics ; Qualitative Research ; Thrombosis/blood ; Thrombosis/diagnosis ; Thrombosis/economics ; Thrombosis/etiology ; Time Factors ; Treatment Outcome ; United Kingdom
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.
    Autorzy:
    Holt TA; Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, England. .
    Fitzmaurice DA
    Marshall T
    Fay M
    Qureshi N
    Dalton AR
    Hobbs FD
    Lasserson DS
    Kearley K
    Hislop J
    Jin J
    Pokaż więcej
    Źródło:
    Trials [Trials] 2013 Nov 13; Vol. 14, pp. 385. Date of Electronic Publication: 2013 Nov 13.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Clinical Protocols*
    Risk Assessment*
    Software*
    Anticoagulants/*therapeutic use
    Atrial Fibrillation/*complications
    Stroke/*etiology
    Automation ; Data Collection ; Ethics, Medical ; Humans ; Pilot Projects ; Sample Size ; Stroke/prevention & control
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    SMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375].
    Autorzy:
    McCahon D; />Fitzmaurice DA
    Murray ET
    Fuller CJ
    Hobbs RF
    Allan TF
    Raftery JP
    Pokaż więcej
    Źródło:
    BMC family practice [BMC Fam Pract] 2003 Sep 18; Vol. 4, pp. 11. Date of Electronic Publication: 2003 Sep 18 (Print Publication: 2003).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Anticoagulants/*administration & dosage
    Self Administration/*economics
    State Medicine/*statistics & numerical data
    Warfarin/*administration & dosage
    Adult ; Anticoagulants/economics ; Cost-Benefit Analysis ; Drug Monitoring/economics ; Humans ; Patient Satisfaction/statistics & numerical data ; State Medicine/economics ; Statistics as Topic/methods ; United Kingdom ; Warfarin/economics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
    Autorzy:
    Turner, Grace M.
    Calvert, Melanie
    Feltham, Max G.
    Ryan, Ronan
    Fitzmaurice, David
    Cheng, K. K.
    Marshall, Tom
    Pokaż więcej
    Temat:
    TRANSIENT ischemic attack prevention
    STROKE prevention
    PREVENTIVE medicine
    ANTICOAGULANTS
    ANTIHYPERTENSIVE agents
    ANTILIPEMIC agents
    DRUGS
    FAMILY medicine
    MEDICAL prescriptions
    PREVENTIVE health services
    RESEARCH funding
    STROKE
    TRANSIENT ischemic attack
    RETROSPECTIVE studies
    Źródło:
    PLoS Medicine; 11/15/2016, Vol. 13 Issue 11, p1-17, 17p, 5 Charts, 2 Graphs
    Terminy geograficzne:
    UNITED Kingdom
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.
    Autorzy:
    Fitzmaurice, David A.
    Accetta, Gabriele
    Haas, Sylvia
    Kayani, Gloria
    Lucas Luciardi, Hector
    Misselwitz, Frank
    Pieper, Karen
    Cate, Hugo
    Turpie, Alexander G. G.
    Kakkar, Ajay K.
    Bassand, Jean‐Pierre
    John Camm, A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Hacke, Werner
    Mantovani, Lorenzo G.
    Eickels, Martin
    Verheugt, Freek W.A.
    Fox, Keith A.A.
    Gersh, Bernard J.
    Pokaż więcej
    Temat:
    VITAMIN K
    STROKE prevention
    ATRIAL fibrillation
    ANTICOAGULANTS
    PLATELET aggregation inhibitors
    Źródło:
    British Journal of Haematology; Aug2016, Vol. 174 Issue 4, p610-623, 14p, 3 Charts, 6 Graphs
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
    Autorzy:
    Apenteng, Patricia N.
    Murray, Ellen T.
    Holder, Roger
    Hobbs, F. D. Richard
    Fitzmaurice, David A.
    Pokaż więcej
    Temat:
    ATRIAL fibrillation
    DISEASE risk factors
    STROKE
    ANTICOAGULANTS
    Źródło:
    BMC Cardiovascular Disorders; 2013, Vol. 13 Issue 1, p1-8, 8p, 2 Diagrams, 1 Chart
    Terminy geograficzne:
    UNITED Kingdom
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
    Autorzy:
    Kakkar, Ajay K.
    Mueller, Iris
    Bassand, Jean-Pierre
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Hacke, Werner
    Lip, Gregory Y. H.
    Mantovani, Lorenzo G.
    Turpie, Alexander G. G.
    van Eickels, Martin
    Misselwitz, Frank
    Rushton-Smith, Sophie
    Kayani, Gloria
    Wilkinson, Peter
    Verheugt, Freek W. A.
    Pokaż więcej
    Temat:
    FIBRINOLYTIC agents
    ANTICOAGULANTS
    ATRIAL fibrillation diagnosis
    STROKE risk factors
    CARDIOVASCULAR diseases
    HEALTH policy
    Źródło:
    PLoS ONE; May2013, Vol. 8 Issue 5, p1-11, 11p
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Trial Protocol: A randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)
    Autorzy:
    Tullett, Jayne
    Murray, Ellen
    Nichols, Linda
    Holder, Roger
    Lester, Will
    Rose, Peter
    Hobbs, F. D. Richard
    Fitzmaurice, David
    Pokaż więcej
    Temat:
    THROMBOSIS
    CARDIOVASCULAR disease treatment
    RESEARCH protocols
    RANDOMIZED controlled trials
    ANTICOAGULANTS
    CARDIOVASCULAR disease prevention
    DISEASE relapse
    Źródło:
    BMC Cardiovascular Disorders; 2013, Vol. 13 Issue 1, p1-11, 11p, 1 Diagram, 3 Charts
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
    Autorzy:
    Mant, Jonathan
    Hobbs, F. D. Richard
    Fletcher, Kate
    Roalfe, Andrea
    Fitzmaurice, David
    Lip, Gregory Y. H.
    Murray, Ellen
    Pokaż więcej
    Temat:
    ATRIAL fibrillation treatment
    MEDICAL care for older people
    WARFARIN
    ASPIRIN
    ANTICOAGULANTS
    BLOOD coagulation
    COUMARINS
    NONSTEROIDAL anti-inflammatory agents
    SAFETY
    Źródło:
    Lancet. 8/11/2007, Vol. 370 Issue 9586, p493-503. 11p.
    Czasopismo naukowe
    Szczegóły
      Wyświetlanie 1-18 z 18

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies